Last reviewed · How we verify

CU-40102 Spray — Competitive Intelligence Brief

CU-40102 Spray (CU-40102 Spray) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Dermatology.

phase 3 Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

CU-40102 Spray (CU-40102 Spray) — Cutia Therapeutics（Wuxi）Co.,Ltd. CU-40102 is a topical spray formulation designed to treat skin conditions, likely through local delivery of an active pharmaceutical ingredient to affected areas.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
CU-40102 Spray TARGET CU-40102 Spray Cutia Therapeutics（Wuxi）Co.,Ltd phase 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). CU-40102 Spray — Competitive Intelligence Brief. https://druglandscape.com/ci/cu-40102-spray. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: